Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 12
144
Views
0
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Agrimoniin inhibits the activity of CYP1A2, 2D6, and 3A4 in human liver microsomes

, , , , , , & show all
Pages 1360-1365 | Received 14 Sep 2021, Accepted 18 Nov 2021, Published online: 28 Nov 2021

References

  • Almazroo OA, Miah MK, Venkataramanan R. 2017. Drug metabolism in the liver. Clin Liver Dis. 21(1):1–20.
  • Dong G, Zhou Y, Song X. 2018. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes. Pharm Biol. 56(1):620–625.
  • Ge GB. 2019. Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system. Chin J Nat Med. 17(11):801–802.
  • Grochowski DM, Skalicka-Woźniak K, Orhan IE, Xiao J, Locatelli M, Piwowarski JP, Granica S, Tomczyk M. 2017. A comprehensive review of agrimoniin. Ann N Y Acad Sci. 1401(1):166–180.
  • Guengerich FP. 2019. Cytochrome P450 research and The Journal of Biological Chemistry. J Biol Chem. 294(5):1671–1680.
  • Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. 2000. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol. 82(2):122–129.
  • Huang YT, Onose J, Abe N, Yoshikawa K. 2009. In vitro inhibitory effects of pulvinic acid derivatives isolated from Chinese edible mushrooms, Boletus calopus and Suillus bovinus, on cytochrome P450 activity. Biosci Biotechnol Biochem. 73(4):855–860.
  • Lang J, Li W, Zhao J, Wang K, Chen D. 2017. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica. 47(10):849–816.
  • Liu J, Zhang N, Li N, Fan X, Li Y. 2019. Influence of verapamil on the pharmacokinetics of oridonin in rats. Pharm Biol. 57(1):787–791.
  • Liu Y, Zhang J, Wu D, Cui L. 2020. Pharmacokinetic interaction study between ligustrazine and valsartan in rats and its potential mechanism. Pharm Biol. 58(1):1290–1293.
  • Lynch T, Price A. 2007. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 76(3):391–396.
  • MacLeod AK, McLaughlin LA, Henderson CJ, Wolf CR. 2017. Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with Antidepressants. Drug Metab Dispos. 45(1):17–22.
  • Manikandan P, Nagini S. 2018. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 19:38–54.
  • Miyamoto K, Kishi N, Koshiura R. 1987. Antitumor effect of agrimoniin, a tannin of Agrimonia pilosa Ledeb., on transplantable rodent tumors. JPN J Pharmacol. 43(2):187–195.
  • Nakajima M, Kobayashi K, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. 1998. Involvement of CYP1A2 in mexiletine metabolism. Br J Clin Pharmacol. 46(1):55–62.
  • Olennikov DN, Kashchenko NI, Chirikova NK, Kuz'mina SS. 2014. Phenolic profile of Potentilla anserina L. (Rosaceae) herb of siberian origin and development of a rapid method for simultaneous determination of major Phenolics in P. anserina pharmaceutical products by microcolumn RP-HPLC-UV. Molecules. 20(1):224–248.
  • Ouyang H, Shen J, Huang X, Ma W, Jia Q, Yao G, Tang Z, Zhang D, Sun M, Teye Azietaku J, et al. 2019. Effect of naoxintong capsules on the activities of CYP450 and metabolism of metoprolol tartrate in rats evaluated by probe cocktail and pharmacokinetic methods. Evid Based Complement Alternat Med. 2019:5242605.
  • Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
  • Thelen K, Dressman JB. 2009. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol. 61(5):541–558.
  • Tornio A, Backman JT. 2018. Cytochrome P450 in pharmacogenetics: an update. Adv Pharmacol. 83:3–32.
  • Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42(1):89–98.
  • Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, Wang ZT, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10(4):496–503.
  • Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. 2014. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos. 42(2):245–249.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.